Stock Market Reviews

Read and share opinions on MNOV (MediciNova, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

Latest News

• MediciNova: Q3 Earnings Snapshot
  Nov 12, 2025
• MediciNova Wins Contract Research and Development Innovation Award at 2025 BioTech Breakthrough Awards
  Nov 6, 2025
• MediciNova Announces Completion of Patient Enrollment in MN-001-NATG-202 Clinical Trial of MN-001 (Tipelukast)
  Nov 4, 2025
• MediciNova compounds demonstrate novel therapeutic approach for Atherosclerosis
  Nov 1, 2025
• MediciNova Compounds Demonstrate Novel Therapeutic Approach for Atherosclerosis in Peer-Reviewed Publication
  Oct 30, 2025
• MediciNova to Present at the LD Micro Main Event XIX Investor Conference
  Oct 6, 2025
• MediciNova Announces Completion of Patient Enrollment in COMBAT-ALS Phase 2b/3 Clinical Trial of MN-166 (ibudilast)
  Sep 22, 2025
• MediciNova Announces Poster Presentation of COMBAT-ALS Clinical Trial at the 36th International Symposium on ALS/MND
  Sep 16, 2025
• MediciNova Provides Shareholder Update on Key Developments
  Sep 8, 2025
• MediciNova to Present at the H.C. Wainwright 27th Annual Global Investment Conference
  Sep 3, 2025
• MediciNova Achieves Enrollment in COMBAT-ALS Clinical Trial
  Aug 26, 2025
• MediciNova: Q2 Earnings Snapshot
  Aug 14, 2025
• MediciNova Announces Signing of a Standby Equity Purchase Agreement for up to $30 Million
  Jul 31, 2025
• MediciNova Provides Enrollment Update for Ongoing ALS and Hypertriglyceridemia Clinical Trials
  Jul 24, 2025
• MediciNova price target lowered to $5 from $6 at B. Riley
  Jun 17, 2025
• MediciNova: Q1 Earnings Snapshot
  May 13, 2025